Accordingto Global Burden of Disease Study, worldwide headache disorders are thethird-highest cause of years lost due to disability. Headache disorders causingdifficulties in family, social, and work life.Ø Types of headaches: Thiscluster is thought to be attributed to nasal problems, migraines, clusterheadaches and other miscellaneous pains in the head and face areas. The main nerve involvedin headache disorders is SPG, a collection of nerve cells that has connectionsto the brainstem and meninges. Inflammation around meninges activates painreceptors and releases pain-causing neurotransmitters.
There is currently no definitive cure forheadache disorders. Theprevalent treatment options, such as oxygen therapy, local anaesthetics(lidocaine, xylocaine), analgesics (aspirin, ibrufopen), sumatriptans,octreotide, and dihydroergotamin aim to reduce the frequency and severity ofattacks. Ø The ati neurostimulation system:AutonomicTechnologies (ATI) has developed the ATI™ Neurostimulator System to deliverlow- level electrical stimulation to provide therapy to relieve the pain ofcluster headache. The ATI Neurostimulator is embedded through a little cut inthe upper gum, and is situated at the SPG nerve pack. It is find right by theclient’s agony. This method leaves no scars. Figure (): Electronic aspirin TheATI Neurostimulator System consists of two separate devices, theneurostimulator and the handheld remote controller, and requires invasivesurgery.
The neurostimulator, shown below, is roughly the size of an almond. Ithas two ends, with one a slender probe. The probe is essentially attached tothe SPG (Sphenopalatine Ganglion) bundle of nerve fibers and the deviceimplanted in the upper mandible (within the gum, usually just below the eyesocket) on the side of the head where the patient suffers most from pain.
Thepatient is then given a small hand-held controller where, upon firstexperiencing the beginning signs of a headache can place the remote directly totheir head to stimulate the device. This stimulation will send electricalimpulses through the device to the SPG bundle, and ultimately prevent thenerves from releasing the neurotransmitters causing the pain (PSC). Patientsalso have the option of having the device removed once condition improves. The device has nohealth-related restrictions and can be implanted into anyone with allergies,high blood pressure, or heart disease, whereas medications such as analgesicsor sumatriptans have to be consumed carefully due to side effects such asincreased blood pressure, allergies, and weight gain: Ø Water survey:1. 75% patients have recordedimprovement in their ability to function normally in their daily lives.2. 68 %patients reported improved, less Pain orfewer headaches.
3. 31% report a decrease in the amount ofheadaches they had weekly.4. 43 %patients found 88% decrease in headaches.
Ø Advantages:1. helppatients who can’t eat pill medicine2. itdoesn’t make introspection by medicine Ø Disadvantages 1. itis a new technology it is expensive (situation in these day)2.
itcauses lots of money to fix3. it’shard to use